Evidence map›Paper›PMID 28190244›Full record

ReviewNaunyn-Schmiedeberg's archives of pharmacology2017

NADPH oxidase: its potential role in promotion of pulmonary arterial hypertension.

Jing-Jie Peng, Bin Liu, Jin-Yun Xu, Jun Peng, Xiu-Ju Luo

Abstract readReview
PubMed Publisher
In one paragraph

Review in Naunyn-Schmiedeberg's archives of pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 23 citations in OpenAlex.

  1. Babassu (Foods (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. RAAS, ACE2 and COVID-19; a mechanistic review.Saudi journal of biological sciences · 2021
    Review
  8. Review
  9. Article
  10. Review
  11. NOX5: Molecular biology and pathophysiology.Experimental physiology · 2019
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Redox Regulation of Inflammatory Processes Is Enzymatically Controlled.Oxidative medicine and cellular longevity · 2017
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jing-Jie PengDepartment of Pharmacology, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410078, China.
Bin LiuDepartment of Pharmacology, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410078, China.
Jin-Yun XuDepartment of Laboratory Medicine, Xiangya School of Medicine, Central South University, Changsha, 410013, China.
Jun PengDepartment of Pharmacology, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410078, China. Junpeng@csu.edu.cn.
Xiu-Ju LuoDepartment of Laboratory Medicine, Xiangya School of Medicine, Central South University, Changsha, 410013, China. xjluo22@csu.edu.cn.
Central South University · CNXiangya Hospital Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

NADPH oxidases (NOXs) are a group of enzymes for superoxide anion (O

Indexed as

AcetophenonesAnimalsHumansHypertension, PulmonaryNADPH OxidasesOnium CompoundsResveratrolStilbenesAcetophenonesacetovanillonediphenyleneiodoniumNADPH OxidasesOnium CompoundsResveratrolStilbenesApocyninDiphenyleneiodoniumNADPH oxidasesPulmonary arterial hypertensionResveratrol

Identifiers

PMID28190244
OpenAlexW2587696901

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.